NCI Workshop on Harmonization of EBV Testing for Nasopharyngeal Cancer
The National Cancer Institute (NCI) is convening a workshop on the harmonization of EBV testing that might have clinical utility in treatment decision-making for advanced nasopharyngeal cancer. The purpose of the workshop is to bring together experts in assay development, clinical laboratory directors, and head and neck oncologists to assess the need for harmonization of EBV testing, identify best approaches to establish harmonization, and explore ways to effect widespread adoption of harmonized assay procedures and references.
- We are extremely proud of the invitation by NCI (NIH) to our inventor Dr. Raymond Ng and molecular genetic consultant Erik Avaniss-Aghajani to participate in the NCI Workshop on Harmonization of EBV Testing for Nasopharyngeal Cancer.
- NCI will use the information discussed in the workshop to prioritize goals for the future and will prepare a white paper summary to help guide researchers worldwide.